Literature DB >> 23556867

The need for performance standards in clinical translation and adoption of fluorescence molecular imaging.

Eva M Sevick-Muraca, Banghe Zhu.   

Abstract

Mesh:

Year:  2013        PMID: 23556867      PMCID: PMC3612123          DOI: 10.1118/1.4789499

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


× No keyword cloud information.
  8 in total

1.  Putting numbers to fluorescent guided surgery.

Authors:  Eben L Rosenthal; Kurt R Zinn
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

2.  Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents.

Authors:  Funda Meric-Bernstam; John C Rasmussen; Savitri Krishnamurthy; I-Chih Tan; Banghe Zhu; Jamie L Wagner; Gildy V Babiera; Elizabeth A Mittendorf; Eva M Sevick-Muraca
Journal:  Biomed Opt Express       Date:  2013-12-13       Impact factor: 3.732

3.  Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.

Authors:  Martin C Boonstra; Berend Tolner; Boudewijn E Schaafsma; Leonora S F Boogerd; Hendrica A J M Prevoo; Guarav Bhavsar; Peter J K Kuppen; Cornelis F M Sier; Bert A Bonsing; John V Frangioni; Cornelis J H van de Velde; Kerry A Chester; Alexander L Vahrmeijer
Journal:  Int J Cancer       Date:  2015-06-22       Impact factor: 7.396

4.  Deglycosylation of mAb by EndoS for improved molecular imaging.

Authors:  Peng Gao; Kenneth L Pinkston; Nathaniel Wilganowski; Holly Robinson; Ali Azhdarinia; Banghe Zhu; Eva M Sevick-Muraca; Barrett R Harvey
Journal:  Mol Imaging Biol       Date:  2015-04       Impact factor: 3.488

5.  Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP.

Authors:  Banghe Zhu; Grace Wu; Holly Robinson; Nathaniel Wilganowski; Mary A Hall; Sukhen C Ghosh; Kenneth L Pinkston; Ali Azhdarinia; Barrett R Harvey; Eva M Sevick-Muraca
Journal:  Mol Imaging Biol       Date:  2013-10       Impact factor: 3.488

6.  Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer.

Authors:  Melissa L Korb; Yolanda E Hartman; Joy Kovar; Kurt R Zinn; Kirby I Bland; Eben L Rosenthal
Journal:  J Surg Res       Date:  2013-11-22       Impact factor: 2.192

7.  EpCAM as multi-tumour target for near-infrared fluorescence guided surgery.

Authors:  P B A A van Driel; M C Boonstra; H A J M Prevoo; M van de Giessen; T J A Snoeks; Q R J G Tummers; S Keereweer; R A Cordfunke; A Fish; J D H van Eendenburg; B P F Lelieveldt; J Dijkstra; C J H van de Velde; P J K Kuppen; A L Vahrmeijer; C W G M Löwik; C F M Sier
Journal:  BMC Cancer       Date:  2016-11-14       Impact factor: 4.430

Review 8.  Optical Molecular Imaging of Inflammatory Cells in Interventional Medicine-An Emerging Strategy.

Authors:  Gavin P Birch; Thane Campbell; Mark Bradley; Kevin Dhaliwal
Journal:  Front Oncol       Date:  2019-09-12       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.